Activation antigens during the proliferative and secretory phases of endometrium and early-pregnancy decidua

Gynecologic and Obstetric Investigation

Volumn 62, Issue 2, 2006, Pages 66-74

  Ugur, Yesim ^a   Cakar, A Nur ^a   Beksac, M Sinan ^a   Dagdeviren, Attila ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Activation antigens; Decidua; Endometrium

Indexed keywords

ANTIGEN; CD30 ANTIGEN; CD70 ANTIGEN; CD71 ANTIGEN; CD98 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD26; MONOCLONAL ANTIBODY CD30; MONOCLONAL ANTIBODY CD70; MONOCLONAL ANTIBODY CD71; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CELL PROLIFERATION; CELL SECRETION; DECIDUA; DECIDUALIZATION; ENDOMETRIUM; ENDOMETRIUM CELL; ENDOTHELIUM; ENDOTHELIUM CELL; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; LARGE GRANULAR LYMPHOCYTE; LUTEAL PHASE; LYMPHOCYTE; MENSTRUAL CYCLE; PRIORITY JOURNAL; TISSUE DIFFERENTIATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD26; ANTIGENS, CD30; ANTIGENS, CD70; ANTIGENS, CD98; DECIDUA; DIPEPTIDYL PEPTIDASE 4; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOLOGIC FACTORS; MENSTRUAL CYCLE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RECEPTORS, TRANSFERRIN; UTERINE DISEASES;

EID: 33746871891     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092375     Document Type: Article

References (72)

1. Hendrickson MR, Kempson RL: Normal histology of the uterus and fallopian tubes; in Sternberg SS (ed): Histology for Pathologists, ed 2. Philadelphia, Lippincott-Raven, 1997, pp 879-927.
2. Tabibzadeh S, Kong QF, Babaknia A: Expression of adhesion molecules in human endometrial vasculature throughout the menstrual cycle. J Clin Endocrinol Metab 1994;79:1024-1032.
3. Lessey BA, Damjanovich L, Coutifaris C, et al: Integrin adhesion molecules in the human endometrium. J Clin Invest 1992;90:188-195.
4. Ulmer AJ, Mattern T, Feller AC, et al: CD26 antigen is a surface dipeptidyl peptidase IV as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7. Scand J Immunol 1990;31:429-435.
5. Dong RP, Kameoka J, Hegen M, et al: Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol 1996;156:1349-1355.
6. Kenny AJ, O'Hare MJ, Gusterson BA: Cell surface peptidases as modulators of growth and differentiation. Lancet 1989;2:785-787.
7. Kameoka J, Tanaka T, Nojima Y, et al: Direct association of adenosine deaminase with a T cell activation antigen. CD26. Science 1993;261:466-469.
8. Morrison ME, Vijayasaradhi S, Engelstein D, et al: A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J Exp Med 1993;177:1135-1143.
9. Schön E, Demuth HU, Eichmann E, et al: Dipeptidyl peptidase IV in human T lymphocytes: impaired function of interleukin-2 and gamma interferon due to specific inhibition of dipeptidyl peptidase IV. Scand J Immunol 1989;29:127-132.
10. Kahne T, Kröning H, Thiel U, et al: Alterations in structure and cellular localization of molecular forms of DP IV/CD26 during T cell activation. Cell Immunol 1996;170:63-70.
11. Callebaut C, Krust B, Jacotot E, et al: T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells. Science 1993;262:2045.
12. Imai K, Maeda M, Fujiwara H, et al: Dipeptidyl peptidase IV as a differentiation marker of the human endometrial glandular cells. Hum Reprod 1992;7:1189-1194.
13. Hanski C, Huhle T, Reutter W: Involvement of plasma membrane DPP IV in fibronectin-mediated adhesion of cells on collagen. Biol Chem Hoppe Seyler 1985;366:1169-1176.
14. Gruss HJ, Dower SK: TNF ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 1995;85:3378-3404.
15. Gedrich RW, Gilfillan MC, Duckett CS, et al: CD30 contains two binding sites with different specificities for members of the TNFR-associated factor family of signal transducing proteins. J Biol Chem 1996;271:12852-12858.
16. Ellis TM, Simms PE, Slivnick DJ, et al: CD30 is a signal transducing molecule that defines a subset of human activated CD45RO+ T cells. J Immunol 1993;151:2380-2389.
17. Falini B, Pileri S, Pizzolo G, et al: CD30 (Ki-1) molecule: a new cytokine receptor of the TNF receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995;85:1-14.
18. Lens SM, De Jong R, Hooibrink B, et al: Phenotype and function of human B cells expressing CD70 (CD27 ligand). Eur J Immunol 1996;26:2964-2971.
19. Maurer D, Fischer GF, Fae I, et al: IgM and IgG but not cytokine secretion is restricted to the CD27+ B lymphocyte subset. J Immunol 1992;148:3700-3705.
20. Kobata T, Agematsu K, Kameoka J, et al: CD27 is a signal transducing molecule involved in CD45RA+ naive T cell co-stimulation. J Immunol 1994;153:5422-5432.
21. Agematsu K, Kobata T, Yang FC, et al: CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. Eur J Immunol 1995;25:2825-2829.
22. Gruss HJ, Scheffrahn I, Hübinger G, et al: The CD30 ligand and CD40 ligand regulate CD54 surface expression and release of this soluble form by cultured Hodgkin and Reed-Sternberg cells. Leukemia 1996;10:829.
23. Ohgimoto S, Tabata N, Suga S, et al: Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. J Immunol 1995;155:3585-3592.
24. Friedman AW, Diaz LA, Moore S, et al: The human 4F2 antigen: evidence for cryptic and non-cryptic epitopes and for a role of 4F2 in human T lymphocyte activation. Cell Immunol 1994;154:253-263.
25. Jacotot E, Callebaut C, Blanco J, et al: HIV envelope glycoprotein induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells. Virology 1996;223:318-330.
26. Fleischer B: CD26: a surface protease involved in T-cell activation. Immunol Today 1994;15:180-184.
27. Nausch I, Mentlein R, Heymann E: The degradation of bioactive peptides and proteins by dipeptidyl peptidase IV from human placenta. Biol Chem Hoppe Seyler 1990;371:1113-1118.
28. Liu WJ, Hansen PJ: Progesterone-induced secretion of dipeptidyl peptidase IV by the uterine endometrium of the ewe and cow that co-stimulates lymphocyte proliferation. Endocrinology 1995;136:779-787.
29. Classen L, Denker HW, Winterhager E: Apical plasma membrane bound enzymes of rabbit uterine epithelium: pattern changes during the periimplantation phase. Histochemistry 1987;87:517-529.
30. Loster K, Zeilinger K, Schuppan D, et al: The cysteine-rich region of DPP IV (CD26) is the collagen-binding site. Biochem Biophys Res Commun 1995;217:341-348.
31. Bauvois B: A collagen binding glycoprotein on the surface of mouse fibroblasts is identified as DPP IV. Biochem J 1988;252:723-731.
32. Dang NH, Torimoto Y, Schlossman SF, et al: Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family. J Exp Med 1990;172:649-652.
33. Yamabe T, Takakura K, Sugie K, et al: Induction of the 2B9 antigen/DPP IV/CD26 on human natural killer cells by IL-2, IL-12 or IL-15. Immunology 1997;91:151-158.
34. Madueno JA, Munoz E, Blazquez V, et al: The CD26 antigen is coupled to protein tyrosine phosphorylation and implicated in CD16-mediated lysis in natural killer cells. Scand J Immunol 1993;37:425-429.
35. Chao KH, Yang YS, Ho HN, et al: Decidual natural killer cytotoxicity decreased in normal pregnancy but not in anembryonic pregnancy and recurrent spontaneous abortion. Am J Reprod Immunol 1995;34:274-280.
36. King A, Loke YW: On the nature and function of human uterine granular lymphocytes. Immunol Today 1991;12:432-435.
37. Hildebrandt M, Arck PC, Kruber S, et al: Inhibition of dipeptidyl peptidase IV (DPP IV, CD26) activity abrogates stress-induced, cytokine-mediated murine abortions. Scand J Immunol 2001;53:449-454.
38. Ruter J, Demuth HU, Arck PC, et al: Inhibition of dipeptidylpeptidase IV (DPPIV, CD26) activity modulates surface expression of CTLA-4 in stress-induced abortions. Adv Exp Med Biol 2003;524:155-163.
39. Sehmsdorf US, Zenclussen AC, Arck P, et al: Human miscarriage is associated with increased number of CD26+ decidual lymphocytes. Scand J Immunol 2004;59:400-407.
40. Ruter J, Hoffmann T, Heiser U, et al: The expression of T-cell surface antigens CTLA-4, CD26, and CD28 is modulated by inhibition of dipeptidylpeptidase IV (DPP IV, CD26) activity in murine stress-induced abortions. Cell Immunol 2002;220:150-156.
41. Sato Y, Fujiwara H, Higuchi T, et al: Involvement of dipeptidyl peptidase IV in extravillous trophoblast invasion and differentiation. J Clin Endocrinol Metab 2002;87:4287-4296.
42. Ruiz P, Nassiri M, Steele B, et al: Cytofluorographic evidence that thymocyte dipeptidyl peptidase IV activity is altered with stage of ontogeny and apoptotic status. Cytometry 1996;23:322-329.
43. De Meester I, Vanham G, Kestens L, et al: Binding of adenosine deaminase to the lymphocyte surface via CD26. Eur J Immunol 1994;24:566-570.
44. Fleischer B: CD26: a surface protease involved in T cell activation. Immunol Today 1994;15:180-184.
45. Knapp W, Rieber P, Dorken B, et al: Towards a better definition of human leucocyte surface molecules. Immunol Today 1989;10:253-258.
46. Torimoto Y, Dang NH, Vivier E, et al: Coassociation of CD26 with CD45 on the surface of human T lymphocytes. J Immunol 1991;147:2514-2517.
47. Tanaka T, Duke-Cohan JS, Kameoka J, et al: Enhancement of antigen-induced T-cell proliferation by soluble CD26/DPP IV. Proc Natl Acad Sci U S A 1994;91:3082-3086.
48. D'Elios MM, Romagnani P, Scaletti C, et al: In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells. J Leukoc Biol 1997;61:539-544.
49. Smith CA, Farrah T, Goodwill RG: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 1994;76:959-962.
50. Hamann D, Hilkens CM, Grogan JL, et al: CD30 expression does not discriminate between human Th1- and Th2-type T cells. J Immunol 1996;156:1387-1391.
51. Ito K, Watanabe T, Horie R, et al: High expression of the CD30 molecule in human decidual cells. Am J Pathol 1994;145:276-280.
52. Papadopoulos N, Galazios G, Anastasiadis P, et al: Human decidual cells can express the Hodgkin's cell-associated antigen Ki-1 (CD30) in spontaneous abortions during the first trimester of gestation. Clin Exp Obstet Gynecol 2001;28:225-228.
53. Makhseed M, Raghupathy R, Azizieh F, et al: Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneous abortions. Hum Reprod 2000;15:2011-2017.
54. Gruss HJ, Pinto A, Gloghini A, et al: CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues. Am J Pathol 1996;149:469-481.
55. Hintzen RQ, De Jong R, Lens SM, et al: CD27: marker and mediator of T cell activation? Immunol Today 1994;15:307-311.
56. Orengo AM, Cantoni C, Neglia F, et al: Reciprocal expression of CD70 and of its receptor, CD27, in human long-term-activated T and natural killer cells: inverse regulation by cytokines and role in induction of cytotoxicity. Clin Exp Immunol 1997;107:608-613.
57. Lens SM, Keehnen RM, Van Oers MH, et al: Identification of a novel subpopulation of germinal center B cells characterized by expression of IgD and CD70. Eur J Immunol 1996;26:1007-1011.
58. Hintzen RQ, Lammers K, Lens SM, et al: Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J Immunol 1995;154:2612-2623.
59. Bowman MR, Crimmins MA, Yetz-Aldape J, et al: The cloning of CD70 and its identification as the ligand for CD27. J Immunol 1994;152:1756-1761.
60. Caruso A, Licenziati S, Corulli M, et al: Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry 1997;27:71-76.
61. Eidukaite A, Tamosiunas V: Endometrial and peritoneal macrophages: expression of activation and adhesion molecules. Am J Reprod Immunol 2004;52:113-117.
62. Haynes BF, Hamler ME, Mann DL, et al: Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol 1981;126:1409-1414.
63. 2+ required for T cell activation. J Immunol 1992;149:1912-1920.
64. Freidman AW, Diaz LA Jr, Moore S, et al: The human 4F2 antigen: evidence for cryptic and noncryptic epitopes and for a role of 4F2 in human T lymphocyte activation. Cell Immunol 1994;154:253-263.
65. Spagnoli GC, Ausiello C, Palma C, et al: Functional effects of a monoclonal antibody directed against a distinct epitope on 4F2 molecular complex in human peripheral blood mononuclear cell activation. Cell Immunol 1991;136:208-218.
66. Nakao M, Kubo K, Hara A, et al: A monoclonal antibody (H227) recognizing a new epitope of 4F2 molecular complex associated with T cell activation. Cell Immunol 1993;152:226-233.
67. 2+ exchanger activity in cardiac and skeletal muscle sarcolemmal vesicles by monoclonal antibody 44D7. J Biol Chem 1986;261:92-95.
68. 2+ mobilization. Biochem J 1987;247:695-700.
69. Blobel CP, Wolfberg TG, Turck CW, et al: A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature 1992;356:248-252.
70. White JM: Viral and cellular membrane fusion proteins. Annu Rev Physiol 1990;52:675-697.
71. Kudo Y, Boyd CA: RNA interference-induced reduction in CD98 expression suppresses cell fusion during syncytialization of human placental BeWo cells. FEBS Lett 2004;577:473-477.
72. Ayuk PT, Sibley CP, Donnai P, et al: Development and polarization of cationic amino acid transporters and regulators in the human placenta. Am J Physiol Cell Physiol 2000;278:C1162-C1171.